FDA Clearance Tracker · P200015-S020
Edwards Alterra Adaptive Prestent System
Last checked: Nov 20, 2026Latest source record: Aug 8, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Aug 8, 2022
Approved
Time to decision
105 days
Received Apr 25, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
The decision
- FDA number
- P200015-S020
- Device name
- Edwards Alterra Adaptive Prestent System
- Applicant
- Edwards Lifesciences, LLC
- Applicant location
- Irvine, CA
- Received
- Apr 25, 2022
- Decided
- Aug 8, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P200015
Device type
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a new e-beam sterilizer for the Alterra Adaptive Prestent System.
Source documents
Other decisions for Edwards Lifesciences, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PASCAL Precision Transcatheter Valve Repair SystemPMA supplement
P220003-S029 · Decided Oct 20, 2026 · 180 days after receipt · Panel Track
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.